Abstract
Background SARS-CoV-2 could infect people at all ages, and the viral shedding and immunological features of children COVID-19 patients were analyzed.
Methods Epidemiological information and clinical data were collected from 35 children patients. Viral RNAs in respiratory and fecal samples were detected. Plasma of 11 patients were collected and measured for 48 cytokines.
Results 40% (14/35) of the children COVID-19 patients showed asymptomatic infections, while pneumonia shown by CT scan occurred in most of the cases (32/35, 91.43%). Elevated LDH, AST, CRP, neutropenia, leukopenia, lymphopenia and thrombocytopenia occurred in some cases, and CD4 and CD8 counts were normal. A total of 22 cytokines were significantly higher than the healthy control, and IP-10, IFN-α2 of them in children were significantly lower than the adult patients. Meanwhile, MCP-3, HGF, MIP-1α, and IL-1ra were similar or lower than healthy control, while significantly lower than adult patients. Viral RNAs were detected as early as the first day after illness onset (d.a.o) in both the respiratory and fecal samples. Viral RNAs decreased as the disease progression and mostly became negative in respiratory samples within 18 d.a.o, while maintained relatively stable during the disease progression and still detectable in some cases during 36~42 d.a.o.
Conclusion COVID-19 in children was mild, and asymptomatic infection was common. Immune responses were relatively normal in children COVID-19 patients. Cytokine storm also occurred in children patients, while much weaker than adult patients. Positive rate of viral RNAs in fecal samples was high, and profile of viral shedding were different between respiratory and gastrointestinal tract.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Ministry of Science and Technology (2020YFC0846300), National Science and Technology Major Project (2018ZX10711001, 2017ZX10103011), Shenzhen Science and Technology Research and Development Project (202002073000001), Sanming Project of Medicine in Shenzhen (SZSM201512005). The funding institutions had no roles in study design, data collection, data analysis, interpretation or writing of the report in this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Ethics Committees of Shenzhen Third People's Hospital. Verbal informed consents were obtained from all patients or patients family members of COVID-19 patients due to the special circumstances that pens and papers were not allowed to be brought into containment facilities.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets supporting the conclusions of this article are included within the article.
Abbreviations
- COVID-19
- Coronavirus Disease 2019
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
- ARDS
- acute respiratory distress syndrome
- qRT-PCR
- Quantitative reverse-transcriptase polymerase chain reaction
- CDFA
- China Food and Drug Administration
- LDH
- lactate dehydrogenase
- AST
- aspartate amino transferase
- CRP
- C-reactive protein
- IL
- interleukin
- HGF
- Hepatocyte growth factor
- MCP-3
- Monocyte chemotactic protein-3
- MIG
- Monokine induced gamma interferon
- M-CSF
- Macrophage colony stimulating factor
- G-CSF
- Granulocyte colony-stimulating factor
- MIP-1α
- Macrophage inflammatory protein 1 alpha
- CTACK
- Cutaneous T-cell-attracting chemokine
- IP-10
- Interferon gamma induced protein 10
